Anchor Capital Advisors LLC Astrazeneca PLC Transaction History
Anchor Capital Advisors LLC
- $3.1 Billion
- Q3 2025
A detailed history of Anchor Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Anchor Capital Advisors LLC holds 114,350 shares of AZN stock, worth $10.2 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
114,350
Previous 116,464
1.82%
Holding current value
$10.2 Million
Previous $8.14 Million
7.79%
% of portfolio
0.28%
Previous 0.26%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...